Ledger.Open graph →
SEC Form D · filed December 22, 2017

Elysium Therapeutics, Inc

Offering
$1.5M
Sold
$652K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DANVILLE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kathy E. Laporte · Danville, CADirectorAlex G. Sturmer · Danville, CAExec · DirectorBob E. Rappaport · Danville, CADirectorThomas E. Jenkins · Danville, CAExec · DirectorAetos Capital Partners GP, LLC · New York, NYExec · DirectorAetos Capital Partners Management, LLC · New York, NYDirectorAneesh Sachdeva · Bellevue, WAExec · DirectorTommaso Furlanello · Bellevue, WADirectorMartin Edwards · Boston, MADirectorMorgan Creek Capital Management, LLC · Chapel Hill, NCExec · DirectorMichael B. Watts · Laguna Hills, CADirectorBryan O'Rear · Ann Arbor, MIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗